{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Tolvaptan  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tolvaptan. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tolvaptan  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "tolvaptan",
    "trial_2_text": "Tolvaptan  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Tolvaptan Supplement: 60 participants will take Tolvaptan 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tolvaptan. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tolvaptan  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.3528696596622467,
      "9": 0.23724351823329926,
      "173": 0.2207481414079666,
      "77": 0.17841656506061554,
      "21": 0.16273106634616852,
      "123": 0.15203751623630524,
      "87": 0.14558088779449463,
      "17": 0.1451316624879837,
      "177": 0.14255692064762115,
      "20": 0.13053767383098602,
      "189": 0.12876205146312714,
      "243": 0.12374111264944077,
      "180": 0.12270835041999817,
      "188": 0.12131206691265106,
      "151": 0.1204608753323555,
      "30": 0.12039794027805328,
      "350": 0.11982591450214386,
      "132": 0.11723890900611877,
      "46": 0.11716160923242569,
      "79": 0.11695389449596405,
      "29": 0.11132292449474335,
      "104": 0.10999339073896408,
      "76": 0.10793333500623703,
      "28": 0.10523522645235062,
      "37": 0.09820492565631866,
      "14": 0.09807334095239639,
      "86": 0.09749076515436172,
      "67": 0.09671855717897415,
      "85": 0.09352205693721771,
      "200": 0.09078213572502136,
      "466": 0.08899795264005661,
      "239": 0.08419276028871536,
      "126": 0.08413971960544586,
      "228": 0.08367233723402023,
      "61": 0.08338579535484314,
      "27": 0.08100926131010056,
      "179": 0.07983206957578659,
      "114": 0.07769286632537842,
      "49": 0.07605250924825668,
      "68": 0.07594477385282516,
      "2": 0.07567266374826431,
      "15": 0.07425504922866821,
      "116": 0.0732448548078537,
      "203": 0.07037294656038284,
      "131": 0.06993622332811356,
      "35": 0.06962074339389801,
      "96": 0.06930111348628998,
      "242": 0.06927812844514847,
      "64": 0.0690753236413002,
      "18": 0.06859391927719116,
      "193": 0.06718939542770386,
      "31": 0.0668414980173111,
      "102": 0.06667890399694443,
      "164": 0.06642088294029236,
      "69": 0.06548799574375153,
      "286": 0.0650237575173378,
      "361": 0.06462376564741135,
      "5": 0.06307067722082138,
      "269": 0.06298936158418655,
      "276": 0.06210843846201897,
      "25": 0.059746816754341125,
      "256": 0.05906328558921814,
      "253": 0.05788791552186012,
      "147": 0.057407040148973465,
      "118": 0.0572669543325901,
      "92": 0.05697424337267876,
      "121": 0.05648435279726982,
      "288": 0.055901043117046356,
      "22": 0.05573991313576698,
      "138": 0.05419231578707695,
      "356": 0.052922364324331284,
      "139": 0.052823279052972794,
      "339": 0.05276605859398842,
      "204": 0.052264291793107986,
      "396": 0.052097003906965256,
      "152": 0.05194369703531265,
      "441": 0.051560692489147186,
      "394": 0.050107479095458984,
      "262": 0.049975406378507614,
      "33": 0.04949164763092995,
      "66": 0.049091637134552,
      "422": 0.0490296445786953,
      "11": 0.04897593334317207,
      "366": 0.04850316792726517,
      "263": 0.04811359569430351,
      "166": 0.04793946072459221,
      "382": 0.047529738396406174,
      "456": 0.047308411449193954,
      "101": 0.04712500423192978,
      "221": 0.046905163675546646,
      "98": 0.046861786395311356,
      "268": 0.04672354832291603,
      "38": 0.04667535051703453,
      "508": 0.04654752090573311,
      "36": 0.04531550779938698,
      "122": 0.04513297230005264,
      "97": 0.04497871175408363,
      "194": 0.04399918019771576,
      "82": 0.04375360161066055,
      "310": 0.04347636550664902
    },
    "trial_2_ae": {
      "78": 0.3528696596622467,
      "9": 0.23724351823329926,
      "173": 0.2207481414079666,
      "77": 0.17841656506061554,
      "21": 0.16273106634616852,
      "123": 0.15203751623630524,
      "87": 0.14558088779449463,
      "17": 0.1451316624879837,
      "177": 0.14255692064762115,
      "20": 0.13053767383098602,
      "189": 0.12876205146312714,
      "243": 0.12374111264944077,
      "180": 0.12270835041999817,
      "188": 0.12131206691265106,
      "151": 0.1204608753323555,
      "30": 0.12039794027805328,
      "350": 0.11982591450214386,
      "132": 0.11723890900611877,
      "46": 0.11716160923242569,
      "79": 0.11695389449596405,
      "29": 0.11132292449474335,
      "104": 0.10999339073896408,
      "76": 0.10793333500623703,
      "28": 0.10523522645235062,
      "37": 0.09820492565631866,
      "14": 0.09807334095239639,
      "86": 0.09749076515436172,
      "67": 0.09671855717897415,
      "85": 0.09352205693721771,
      "200": 0.09078213572502136,
      "466": 0.08899795264005661,
      "239": 0.08419276028871536,
      "126": 0.08413971960544586,
      "228": 0.08367233723402023,
      "61": 0.08338579535484314,
      "27": 0.08100926131010056,
      "179": 0.07983206957578659,
      "114": 0.07769286632537842,
      "49": 0.07605250924825668,
      "68": 0.07594477385282516,
      "2": 0.07567266374826431,
      "15": 0.07425504922866821,
      "116": 0.0732448548078537,
      "203": 0.07037294656038284,
      "131": 0.06993622332811356,
      "35": 0.06962074339389801,
      "96": 0.06930111348628998,
      "242": 0.06927812844514847,
      "64": 0.0690753236413002,
      "18": 0.06859391927719116,
      "193": 0.06718939542770386,
      "31": 0.0668414980173111,
      "102": 0.06667890399694443,
      "164": 0.06642088294029236,
      "69": 0.06548799574375153,
      "286": 0.0650237575173378,
      "361": 0.06462376564741135,
      "5": 0.06307067722082138,
      "269": 0.06298936158418655,
      "276": 0.06210843846201897,
      "25": 0.059746816754341125,
      "256": 0.05906328558921814,
      "253": 0.05788791552186012,
      "147": 0.057407040148973465,
      "118": 0.0572669543325901,
      "92": 0.05697424337267876,
      "121": 0.05648435279726982,
      "288": 0.055901043117046356,
      "22": 0.05573991313576698,
      "138": 0.05419231578707695,
      "356": 0.052922364324331284,
      "139": 0.052823279052972794,
      "339": 0.05276605859398842,
      "204": 0.052264291793107986,
      "396": 0.052097003906965256,
      "152": 0.05194369703531265,
      "441": 0.051560692489147186,
      "394": 0.050107479095458984,
      "262": 0.049975406378507614,
      "33": 0.04949164763092995,
      "66": 0.049091637134552,
      "422": 0.0490296445786953,
      "11": 0.04897593334317207,
      "366": 0.04850316792726517,
      "263": 0.04811359569430351,
      "166": 0.04793946072459221,
      "382": 0.047529738396406174,
      "456": 0.047308411449193954,
      "101": 0.04712500423192978,
      "221": 0.046905163675546646,
      "98": 0.046861786395311356,
      "268": 0.04672354832291603,
      "38": 0.04667535051703453,
      "508": 0.04654752090573311,
      "36": 0.04531550779938698,
      "122": 0.04513297230005264,
      "97": 0.04497871175408363,
      "194": 0.04399918019771576,
      "82": 0.04375360161066055,
      "310": 0.04347636550664902
    }
  },
  "safety": {
    "trial_1_safety": 0.5322163701057434,
    "trial_2_safety": 0.5322163701057434
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.48206618428230286
  }
}